NCT02822495 2023-06-15
Expanded Access Protocol for Tabelecleucel for Patients With Epstein-Barr Virus-Associated Viremia or Malignancies
Atara Biotherapeutics
No longer available
Atara Biotherapeutics
Ontario Clinical Oncology Group (OCOG)
National Institute of Allergy and Infectious Diseases (NIAID)